| mRNA |
Sorafenib |
FIMM |
pan-cancer |
AAC |
-0.041 |
0.8 |
| mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |
| mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.8 |
| mRNA |
AZD6244 |
FIMM |
pan-cancer |
AAC |
0.041 |
0.9 |
| mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
-0.0097 |
0.9 |
| mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.9 |
| mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
XMD8-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.0085 |
0.9 |